Health ❯ Clinical Research

Trial Phases

Phase 3 Trials Safety Trials Phase 2 Trials Efficacy Studies

Metsera’s Obesity Drug Posts 14% Placebo-Adjusted Weight Loss, Bolstering Pfizer Buyout Case

Topline results strengthen the case for a late-2025 Phase 3 start under Pfizer ownership.

Acadia Halts Carbetocin for Prader-Willi After Phase 3 Miss